⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma

Official Title: An Open-Label, Multicenter, Phase III Trial of ABI-007 vs Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma

Study ID: NCT00864253

Interventions

ABI-007
Dacarbazine

Study Description

Brief Summary: The main purpose of this research study is to compare the safety, tolerability, and anti tumor activity of an investigational drug, ABI-007 versus Dacarbazine in patients with metastatic melanoma who have not previously received chemotherapy. ABI-007 is a new preparation of the active drug paclitaxel. It contains the same medication as the prescription chemotherapy drug Abraxane®. Abraxane® is approved by the FDA for the treatment of metastatic breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Dacarbazine is approved by the FDA for the treatment of melanoma. In this study, ABI-007 and Dacarbazine will be tested as therapy for people who have not yet had any cancer treatment for the diagnosis of metastatic melanoma.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

University of Alabama at Birmingham, Birmingham, Alabama, United States

AZ Cancer Ctr, Scottsdale, Arizona, United States

Arizona Cancer Center, Tucson, Arizona, United States

Genesis Cancer Ctr - Hot Springs, Hot Springs, Arkansas, United States

University of Arkansa for Medical Sciences, Little Rock, Arkansas, United States

Tower Cancer Research Foundation, Beverly Hills, California, United States

San Diego Pacific Oncology and Hematology Associates, Encinitas, California, United States

Loma Linda University Cancer Center, Loma Linda, California, United States

University of Southern California/Norris Cancer Center, Los Angeles, California, United States

University of CA Los Angeles, Los Angeles, California, United States

St. Mary's Medical Center, San Francisco, California, United States

University of Colorado Cancer Center, Aurora, Colorado, United States

Baptist Cancer Institute, Jacksonville, Florida, United States

Lakeland Regional Cancer Center, Lakeland, Florida, United States

University of Miami Hospital and Clincs/SCCC, Miami, Florida, United States

Waren Billhartz Cancer Center, Maryville, Illinois, United States

Indiana University, Indianapolis, Indiana, United States

IA Blood and Cancer Care, PLC, Cedar Rapids, Iowa, United States

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Wayne State University, Detroit, Michigan, United States

University of Minnesota, Minneapolis, Minnesota, United States

Saint Louis University, Saint Louis, Missouri, United States

St. John's Medical Research, Springfield, Missouri, United States

Nevada Cancer Institute, Las Vegas, Nevada, United States

Atlantic Melanoma Center, Morristown, New Jersey, United States

Piedmont Hematology, Winston-Salem, North Carolina, United States

OH State University Arthur G. James Cancer Hospital, Columbus, Ohio, United States

Integris Cancer Institute of OK, Oklahoma City, Oklahoma, United States

St. Luke's Hospital & Health Network, Bethlehem, Pennsylvania, United States

Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Mary Crowley Research Center, Dallas, Texas, United States

Univ of TX MD Anderson Cancer Ctr, Houston, Texas, United States

Univ of TX Med School at Houston, Houston, Texas, United States

Covenant Health System DBA Joe Arrington Cancer Research and Treatment Center, Lubbock, Texas, United States

Hope Oncology, Richardson, Texas, United States

Utah Cancer Specialist, Salt Lake City, Utah, United States

Univ. of Washington Medical Center/Seattle Cancer Care Alliance, Seattle, Washington, United States

Evergreen Hematology & Oncology, Spokane, Washington, United States

Port Macquarie Base Hospital, Port Macquarie, New South Wales, Australia

Royal North Shore Hospital, Sydney, New South Wales, Australia

Sydney West Cancer Trials Centre/Westmead Hospital, Westmead, New South Wales, Australia

Royal Adelaide Hospital, Department of Medical Oncology, Adelaide, South Australia, Australia

Royal Hobart Hospital, Hobart, Tasmania, Australia

Alfred Hospital, Melbourne, Victoria, Australia

Sir Charles Gairdner Hospital, Nedlands Perth, Western Australia, Australia

Royal Perth Hospital, Perth, Western Australia, Australia

Tom Baker Cancer Centre, Calgary, Alberta, Canada

Cross Cancer Institute, Edmonton, Alberta, Canada

BCCA Centre for the Southern Interior, Kelowna, British Columbia, Canada

BCCA, Centre for the Southern Interior, Kelowna, British Columbia, Canada

BC Cancer Agency-Fraser Valley Ctr., Surrey, British Columbia, Canada

BC Cancer Agency-Vancouver, Vancouver, British Columbia, Canada

BC Cancer Agency-Vancouver Island Ctr., Victoria, British Columbia, Canada

London Regional Cancer Program, London, Ontario, Canada

Credit Valley Hospital, Missiauga, Ontario, Canada

The Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario, Canada

Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

McGill University Dept. of Oncology Clinical Research Program, Montreal, Quebec, Canada

Hopital Saint Andre' CHU de Bordeaux, Bordeaux, , France

Centre Hospitaller Universitaire de Grenoble, Grenoble Cedex 09, , France

CHRU Hopital Claude Huriez, Lile Cedax, , France

Hopital Dypuytren-CHU de Limoges, Limoges cedex, , France

Centre Leon Berad, Lyon, , France

Hopital Sainte Marguerite, Marseille Cedex 9, , France

CHU Hopital Saint Eloi, Montepellier Cedex 5, , France

Centre Regional Val d' Aurelle Paul Lamarque, Montpellier, , France

Hopital de 1 Archet 2, Nice Cedex 3, , France

Hopital Saint-Louis, Paris Cedex, , France

Hopital Bichat, Paris, , France

Groupe hospitalier Cochin-St. Vincent de Paul, Paris, , France

Institut Gustave Roussy (IGR) Centre de Lutte Contre le Canc, Villejuif Cedex, , France

Charite Universitaetsmedizin Berlin, Berlin, BE, Germany

Universitaetsklinkum Heidelberg, Heidelberg, BW, Germany

Universitaetsklinkum Heidelberg, Heidelber, BW, Germany

Universitaetsklinkum Tuebingen, Tuebingen, BW, Germany

Universitaetsklinkum Wuerzburg PS, Wuerzburg, BY, Germany

Universitaetsklinkum Hamburg-Eppendorf, Hamburg, HH, Germany

Univeritaetsklinkum Goettingen, Gottington, NI, Germany

Medizinische Hochschuke Hannover, Hannover, NI, Germany

St. Josef-Hospital, Bochum, Northwest, Germany

Universitaetsklinkum Essen, Essen, Northwest, Germany

Universitaetklinkum Koeln, Koln, Northwest, Germany

Universitaetsklinkum Schegwig-Holstein, Keil, SH, Germany

Universitaetsklinkum Dresden, Dresden, SN, Germany

UniversitawtsklinKum Jena, Jena, Strasse 35, Germany

Universitaesklinkum Leipzig, Leipzig, , Germany

Universitaetsklinkum Mainz, Mainz, , Germany

Istituto Tumori "Giovanni Paolo II", Bari, BA, Italy

Istituto Scientifico Romagnolo per lo Studio e la Cura dei T, Meldola, FC, Italy

IST-Istituto Nazionale per la Ricera sul Cancro, Genova, GE, Italy

Istituto Europeo di Oncologia, Milano, MI, Italy

Istituto Nazionale Tumori, Milano, MI, Italy

IOV-Instituto Oncologico IRCCS, Padova, PD, Italy

Azienda Ospedaliera Universitaria Sense, Siena, SI, Italy

Ist. Naz. per lo studio e la cura dei tumori G. Pascale, Napoli, , Italy

Ospedale S. Chiara, Pisa, , Italy

Medisch Centrum Alkmaar, Alkmaar, , Netherlands

Rijnstate ziekenhuis Arnhem, Amhem, , Netherlands

Erasmus MC ae" Daniel den Hoed, Rotterdam, , Netherlands

H Clinic i Provincial, Barcelona, , Spain

H CLINIC I Provincial, Barcelona, , Spain

H Clinico San Carlos, Madrid, , Spain

Corporacion Sanitaria Parc Tauli, Sabadell, , Spain

Broomfield Hospital, Chelmsford, Essex, United Kingdom

Velindre Hospital, Cardiff, Glam, United Kingdom

St. George's Hospital, London, GT Lon, United Kingdom

Nottingham University Hospitals NHS Trust, Nottingham, Nott, United Kingdom

Singleton Hospital, Sothwest Wales Inst., Swansea, S Glam, United Kingdom

Univ Hospital of North Staffordshire, Stroke On Kent, Staffs, United Kingdom

Weston Park Hospital, Sheffield, Syorks, United Kingdom

Newcross Hospital, Wolverhampton, Wstmid, United Kingdom

Royal Marsden Hospital London, London, , United Kingdom

Contact Details

Name: Evan Hersh, MD

Affiliation: University of Arizona

Role: PRINCIPAL_INVESTIGATOR

Name: Ileana Elias, MD

Affiliation: Celgene Corporation

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: